MARGINUM

Pioneering the next-generation quantitative surgical techniques

We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows.

Rethinking surgery.

Marginum is developing groundbreaking tissue recognition technology, especially for oncological surgery.

Our technology enables safe and efficient identification of cancerous tissue with minimal damage to healthy tissues. 

OUR SOLUTION

Unforeseen control

Precise detection of tumour without additional invasive steps – based on internationally awarded research.

READ MORE

marginum product img

LATEST NEWS & PRESS

28.6.2024 | Marginum News

Marginum quality management system ISO 13485:2016 certified

The quality management system of Marginum has been assessed and certified as meeting the requirements of ISO 13485:2016 and EN ISO 13485:2016.

10.11.2023 | Marginum News

Marginum raises €1.7 million for market entry of tissue sensing technology for cancer surgery

Almaral, Nostetta Ventures, and Redstone led the investment into Finnish medical technology company Marginum, coupled with Business Finland R&D loan.

22.3.2023 | Marginum News

Marginum started clinical trials of a new technique for tumour surgery

Marginum Ltd has initiated its first-in-human clinical trials with the aspirate tissue monitor at the Kuopio University Hospital.

21.2.2023 | Tahko Ski Lift Pitch

Marginum – Next-generation technology for cancer surgery

Tahko Ski Lift Pitch winner Marginum is pioneering optic tissue monitoring with groundbreaking innovation borne from multidisciplinary UEF research.

10.10.2022 | Kuopio Chamber of Commerce

TSLP winner Marginum increases the efficiency of cancer surgery

Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.

4.10.2022 | University of Eastern Finland

Marginum selected by University of Eastern Finland to Stage Two

Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.

ABOUT US

Dedication
to improve

Marginum is enabling better surgical performance and patient outcomes to answer the globally growing need for efficient oncological treatments.

READ MORE

FOR INVESTORS

We are the pioneers of aspirate tissue monitoring

Founded in 2020, Marginum is reforging the 
technology of oncological surgery

With the developed tissue detection technology for surgery, Marginum aims to make a real impact by helping millions of patients and surgical professionals around the globe.

MARGINUM FOR INVESTORS

OUR PARTNERS

Enabling disruptive innovations

Almaral - Marginum
Nostetta
Redstone
Kuopio University Hospital
University of Eastern Finland
Business Finland
EU logo transport
EU co-funded logo
QMS Certification Logo

CONTACT

Contact us and learn more about the next steps of our mission. 

Location: Kuopio, Finland

Email: info@marginum.com